Abstract
Novel, negatively charged, human serum albumins display potent and selective in vitro anti-human immunodeficiency virus type 1 activity.
R W Jansen, D Schols, R Pauwels, E De Clercq and D K Meijer
Molecular Pharmacology November 1993, 44 (5) 1003-1007;